DENV inhibits type I IFN production in infected cells by cleaving human STING.
DENV inhibits type I IFN production in infected cells by cleaving human STING.
复制标题
DOI：
10.1371/journal.ppat.1002934
复制
发表时间：
2012
期刊：
影响因子：
6.7
通讯作者：
Fernandez-Sesma A
中科院分区：
文献类型：
--
作者：
Aguirre S;Maestre AM;Pagni S;Patel JR;Savage T;Gutman D;Maringer K;Bernal-Rubio D;Shabman RS;Simon V;Rodriguez-Madoz JR;Mulder LC;Barber GN;Fernandez-Sesma A
Dengue virus (DENV) is a pathogen with a high impact on human health. It replicates in a wide range of cells involved in the immune response. To efficiently infect humans, DENV must evade or inhibit fundamental elements of the innate immune system, namely the type I interferon response. DENV circumvents the host immune response by expressing proteins that antagonize the cellular innate immunity. We have recently documented the inhibition of type I IFN production by the proteolytic activity of DENV NS2B3 protease complex in human monocyte derived dendritic cells (MDDCs). In the present report we identify the human adaptor molecule STING as a target of the NS2B3 protease complex. We characterize the mechanism of inhibition of type I IFN production in primary human MDDCs by this viral factor. Using different human and mouse primary cells lacking STING, we show enhanced DENV replication. Conversely, mutated versions of STING that cannot be cleaved by the DENV NS2B3 protease induced higher levels of type I IFN after infection with DENV. Additionally, we show that DENV NS2B3 is not able to degrade the mouse version of STING, a phenomenon that severely restricts the replication of DENV in mouse cells, suggesting that STING plays a key role in the inhibition of DENV infection and spread in mice. Dengue virus (DENV) is a pathogen with a high impact in human health that replicates in a wide range of cells of the immune system. To efficiently infect humans, DENV must evade or inhibit fundamental elements of the innate immune system, namely the type I interferon response (IFN). Thus, DENV can inhibit type I IFN signaling (described by several groups), and type I IFN production (described by our group). We documented the inhibition of type I IFN production in human monocyte derived dendritic cells (MDDCs) with an otherwise strong cytokine and chemokine profile in those cells and that the NS2B3 protease complex of DENV functions as an antagonist of type I IFN production, and its proteolytic activity is necessary for this event. Here we identify the human adaptor molecule STING as a target of the NS2B3 protease complex and characterize the mechanism of inhibition of the type I IFN production in primary human MDDCs mediated by this viral factor. We also describe that DENV NS2B3 cannot degrade the mouse version of STING, a phenomenon that strictly restricts the replication of DENV in mouse cells, suggesting that STING plays a key role in the inhibition of DENV infection and spread in mice.
登录
查看更多内容
影响因子：
5.4
作者：
Boonnak, Kobporn;Dambach, Kaitlyn M.;Marovich, Mary A.
通讯作者：
Marovich, Mary A.
影响因子：
4.8
作者：
Clum, S;Ebner, KE;Padmanabhan, R
通讯作者：
Padmanabhan, R
影响因子：
5.4
作者：
Kopecky-Bromberg, Sarah A.;Martinez-Sobrido, Luis;Palese, Peter
通讯作者：
Palese, Peter
影响因子：
12.7
作者：
Kou, Zhihua;Quinn, Matthew;Jin, Xia
通讯作者：
Jin, Xia
影响因子：
5.2
作者：
Baum, Alina;Garcia-Sastre, Adolfo
通讯作者：
Garcia-Sastre, Adolfo